Literature DB >> 16698941

New insights into the regulation of TLR signaling.

Sinead M Miggin1, Luke A J O'Neill.   

Abstract

Toll-like receptor (TLR) activation is dictated by a number of factors including the ligand itself and the localization of the receptor, in terms of expression profile and subcellular localization and the signal transduction pathway that has been activated. Recent work into TLR signal transduction has revealed complex regulation at a number of different levels including regulation by phosphorylation, targeted degradation, and sequestration of signaling molecules. Here, we describe recent advances that have been made in our understanding of how TLR signaling is regulated at the biochemical level.

Mesh:

Substances:

Year:  2006        PMID: 16698941     DOI: 10.1189/jlb.1105672

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  76 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

Review 2.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

3.  Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88.

Authors:  Yuri A Blednov; Mendy Black; Julia Chernis; Adriana Da Costa; Jody Mayfield; R Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2017-02-01       Impact factor: 3.455

Review 4.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

5.  Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses.

Authors:  Suzanne L Tomchuck; Kevin J Zwezdaryk; Seth B Coffelt; Ruth S Waterman; Elizabeth S Danka; Aline B Scandurro
Journal:  Stem Cells       Date:  2007-10-04       Impact factor: 6.277

Review 6.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

7.  Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP.

Authors:  Girish K Radhakrishnan; Qiqi Yu; Jerome S Harms; Gary A Splitter
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

8.  A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway.

Authors:  Ryan P Nolan; Andrea G Bree; Anup Zutshi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-09-26       Impact factor: 2.745

9.  Biochemical and functional analysis of TIR domain containing protein from Brucella melitensis.

Authors:  Girish K Radhakrishnan; Gary A Splitter
Journal:  Biochem Biophys Res Commun       Date:  2010-05-13       Impact factor: 3.575

10.  TLR2 and TLR4 as Potential Biomarkers of Environmental Particulate Matter Exposed Human Myeloid Dendritic Cells.

Authors:  Marc A Williams; Chris Cheadle; Tonya Watkins; Anitaben Tailor; Smruti Killedar; Patrick Breysse; Kathleen C Barnes; Steve N Georas
Journal:  Biomark Insights       Date:  2007-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.